Bicara Therapeutics BCAX
NASDAQ BCAX
$17.50 -0.41 (-2.32%)
As of: Oct 22, 2026 · 11:03 AM EDT

Bicara Therapeutics (BCAX) Change in Other Operating Assets (2023 - 2026)

Updated

Analysis

Bicara Therapeutics (BCAX) Change in Other Operating Assets (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Assets Change (Qtr)
1 Eli Lilly 1,171.06 Bn 1,139.65 Bn 19.71 Bn -
2 Johnson & Johnson 634.89 Bn 553.42 Bn 17.26 Bn -950.00 Mn
3 AbbVie 503.32 Bn 476.44 Bn 12.70 Bn 188.00 Mn
4 Merck 377.44 Bn 331.82 Bn 12.21 Bn -
5 Novartis Ag 303.91 Bn 267.90 Bn 11.24 Bn -
6 Astrazeneca 267.03 Bn 240.72 Bn 12.86 Bn -
7 Amgen 241.88 Bn 197.28 Bn 7.24 Bn 330.00 Mn
8 Gilead Sciences 194.01 Bn 168.20 Bn 6.22 Bn 13.00 Mn
9 Pfizer 172.57 Bn 119.21 Bn 10.94 Bn -
10 Bicara Therapeutics 1.19 Bn -547.51 Mn - 1.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.40 Mn
Mar 31, 2026 -2.09 Mn
Dec 31, 2025 -839,000.00
Sep 30, 2025 301,000.00
Jun 30, 2025 -627,000.00
Mar 31, 2025 -4.12 Mn
Dec 31, 2024 16.57 Mn
Sep 30, 2024 108,000.00
Jun 30, 2024 -63,000.00
Mar 31, 2024 235,000.00
Dec 31, 2023 59,000.00
API Access

Bicara Therapeutics Change in Other Operating Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-assets&ticker=BCAX&period=max&api_key=YOUR_API_KEY